Barbaro Fund Supports Laminitis Research

Newsdate: Mon, 17 Oct 2011 - 08:46 am
Location: LEXINGTON, Kentucky

The National Thoroughbred Racing Association’s (NTRA) subsidiary, NTRA Charities, announced today that the Barbaro Fund for Equine Health and Safety Research has disbursed $49,000 to support the second year of a research project on laminitis.

The funds from the Barbaro Fund for Equine Health and Safety Research will support: “In Vivo Gene Transfer for the Treatment of Laminitis,” by Dr. Dean Richardson at the University of Pennsylvania. The project seeks to develop a gene therapy approach to prevent laminitis in the contralateral hoof when a horse is being treated for a musculoskeletal injury.

The balance of the “In Vivo Gene Transfer for the Treatment of Laminitis” project costs in 2011 — $14,924 — will be funded by the Grayson-Jockey Club Research Foundation. The Barbaro Fund for Equine Health and Safety Research also supported this project in 2010 through the Grayson-Jockey Club Research Foundation.

“We are proud to continue our support of this important laminitis project, which has already come up with some promising preliminary data,” said NTRA President and CEO Alex Waldrop, who is also the president of NTRA Charities. “We thank Pfizer Animal Health for its continued strong support of the Barbaro Fund for Equine Health and Safety Research. Pfizer’s generosity — along with the contributions of so many of Barbaro’s fans — have kept Barbaro’s memory alive in this very constructive way.”

Since Barbaro’s passing, hundreds of his fans have given to his legacy fund. And in 2008, Pfizer Animal Health teamed up with the NTRA to generate funding for laminitis and equine safety research. 

Thanks to these efforts, the Barbaro Fund for Equine Health and Safety Research has disbursed almost $400,000 in support of conferences, research programs and several research projects — virtually all focused on finding a cure for laminitis, the painful and often fatal hoof disease that plagued Barbaro for so much of his recuperative period following his injury in the 2006 Preakness Stakes.

Formed in 1999 as a subsidiary of the National Thoroughbred Racing Association (NTRA), NTRA Charities is a nonprofit, 501 (c) (3) public charity whose mission is to promote and support charities in or related to the Thoroughbred industry.

About the Author

Flossie Sellers

Author picture

As an animal lover since childhood, Flossie was delighted when Mark, the CEO and developer of EquiMed asked her to join his team of contributors.

She enrolled in My Horse University at Michigan State and completed a number of courses in everything related to horse health, nutrition, diseases and conditions, medications, hoof and dental care, barn safety, and first aid.

Staying up-to-date on the latest developments in horse care and equine health is now a habit, and she enjoys sharing a wealth of information with horse owners everywhere.

Subscribe